Table 3.
Patient Characteristics
| Stage A n=1875 | Stage C n=1875 | p | |
|---|---|---|---|
| Patient age | (n=1660) | (n=1689) | |
| Mean (SD) | 69 (11.7) | 69 (11.1) | 0.449* |
| Median (range) | 70 (7–99) | 69 (22–99) | |
| Sex | (n=1764) | (n=1756) | |
| Male | 15% | 16% | 0.367* |
| Female | 85% | 84% | |
| BMD Results by DXA | (n=1875) | (n=1875) | |
| Normal (T-score ≥−1.0)† | 13% | 17% | <0.001* |
| Low bone mass (T-score between −1.0 and −2.5) | 33% | 35% | |
| Osteoporosis (T-score ≤−2.5) | 37% | 39% | |
| No result documented | 17% | 10% |
*
p value applies to the change within the group of data analyzed.
†
Indicates the patient does not have osteoporosis or low bone mass, therefore additional questions regarding patient care were not completed.